tetraethylammonium has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariano, MA | 1 |
| Cepeda, C | 1 |
| Calvert, CR | 1 |
| Flores-Hernández, J | 1 |
| Hernández-Echeagaray, E | 1 |
| Klapstein, GJ | 1 |
| Chandler, SH | 1 |
| Aronin, N | 1 |
| DiFiglia, M | 1 |
| Levine, MS | 1 |
1 other study available for tetraethylammonium and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Striatal potassium channel dysfunction in Huntington's disease transgenic mice.
Topics: Age Factors; Analysis of Variance; Animals; Cesium; Disease Models, Animal; Dose-Response Relationsh | 2005 |